Cell based immune therapy for patients with skincancer

Registry ID

EUCTR2014-001420-29

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Center for Cancer Immune Therapy

Start date

2014-07-03

Last update

2026-08-16

Conditions

• malignant melanoma

Summary

to evaluate toxicity (according to CTCAE version 4.0) and feasibility

Locations

• , , Denmark

View on source registry